The microbiome and mental health: looking back, moving forward with lessons from allergic disease
High prices, confusing systems, and too many barriers between patients and the care they need
These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders
Best for: Patients with widespread hair thinning who also want the anti-aging, skin-rejuvenation, and wound-healing benefits of systemic copper peptide therapy
Unlike SGLT2 inhibitors, semaglutide does not have diuretic properties and is not associated with increased urination as a direct side effect according to FDA prescribing information
Cells depleted of glutathione are susceptible to damage